What We're Reading: COVID-19 Plasma Treatment Receives EUA; Research on Reopening Schools; Mask Mandates
The FDA issued an emergency use authorization (EUA) for convalescent plasma to treat coronavirus disease 2019 (COVID-19); limited transmission of COVID-19 was reported in reopened childcare centers; universal mask mandates could save lives.
FDA Issues Emergency Use Authorization for COVID-19 Plasma Treatment
Yesterday, the FDA
CDC Director Addresses Reopening of Schools, Child Care Programs
According to a
Study Suggests Mask Wearing Can Save 70,000 Lives in Near Future
According to a projection by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Rural-Urban Disparities in Colorectal Cancer Screening Persist
September 21st 2025
- AML Survival After 3 Years in Remission Comparable With General Population
September 20th 2025
- AHA Launches New Initiative to Help Patients With Heart Failure
September 20th 2025
- CSU More Burdensome in Female Patients, Especially in Midlife
September 20th 2025
- Pirtobrutinib Shows Clinically Meaningful PFS Improvement in Frontline CLL
September 19th 2025